<- Go Home
Longevity Acquisition Corporation
Longevity Acquisition Corporation does not have significant operations. The company focuses on acquiring, engaging in a share exchange, share reconstruction and amalgamation, purchasing of assets, entering into contractual arrangements, or other business combination with one or more businesses. Longevity Acquisition Corporation was founded in 2018 and is based in Shanghai, the People’s Republic of China. As of March 22, 2021, Longevity Acquisition Corporation operates as a subsidiary of 4D pharma plc.
Market Cap
$35.3M
Volume
18.2K
Cash and Equivalents
$19.3K
EBITDA
N/A
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$19.25
52 Week Low
$10.24
Dividend
N/A
Price / Book Value
7.06
Price / Earnings
-37.03
Price / Tangible Book Value
7.06
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$785.2K
Return on Equity
11.72%
Return on Assets
-1.73
Cash and Short Term Investments
$19.3K
Debt
$2.0M
Equity
$5.0M
Revenue
N/A
Unlevered FCF
-$82.8K
Sector
Capital Markets
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium